SphK1-IN-2
SphK1-IN-2 is a potent, selective SphK1 inhibitor with IC50 values of 19.81 nM and >10 μM for SphK1 and SphK2, respectively. SphK1-IN-2 exhibits anti-proliferative activities and induces cell cycle arrest and apoptosis. SphK1-IN-2 can be used for cancer research.
For research use only. We do not sell to patients.
- CAS No.: 3031483-60-7
- Formula: C27H30BrNO4S
- Molecular Weight:544.50
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
SphK1 19.81 nM (IC50) |
SphK2 >10 μM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-29 | IC50 |
3.85 μM
Compound: 28
|
Antiproliferative activity against human HT-29 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human HT-29 cells incubated for 72 hrs by SRB assay
|
[PMID: 35439002] |
| MCF7 | IC50 |
4 μM
Compound: 28
|
Antiproliferative activity against human MCF7 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells incubated for 72 hrs by SRB assay
|
[PMID: 35439002] |
| MDA-MB-231 | IC50 |
7.14 μM
Compound: 28
|
Antiproliferative activity against human MDA-MB-231 cells for 72 hrs by SRB assay
Antiproliferative activity against human MDA-MB-231 cells for 72 hrs by SRB assay
|
[PMID: 35439002] |
| SW480 | IC50 |
4 μM
Compound: 28
|
Antiproliferative activity against human SW480 cells incubated for 72 hrs by SRB assay
Antiproliferative activity against human SW480 cells incubated for 72 hrs by SRB assay
|
[PMID: 35439002] |
SphK1-IN-2 (4-24 μM; 72 hours; cancer cell lines) has anti-proliferative activity on cancer cells[1].
SphK1-IN-2 (10-30 μM; 48 hours; HT-29 cells and MDA-MB-231 cells) induces G0/G1 phase arrest and apoptosis in colon cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HT-29, SW480, MDA-MB231 and MCF-7 cells
-
Concentration:4-24 μM
-
Incubation Time:72 hours
-
Result:Had inhibitory activity against HT-29 and MDA-MB-231 with IC50 of 3.85 and 7.14 μM, respectively.
-
Cell Line:HT-29 cells and MDA-MB-231 cells
-
Concentration:10 and 30 μM
-
Incubation Time:72 hours
-
Result:Arrestd cell cycle at G0/G1 phase and reduced the expression of cyclin A, cyclin E1, cyclin D1, and CDK6.
-
Cell Line:HT-29 cells and MDA-MB-231 cells
-
Concentration:10 and 30 μM
-
Incubation Time:48 hours
-
Result:Induced cell apoptosis in a dose-dependent manner.
SphK1-IN-2 (2-50 mg/kg; p.o., i.p. and i.v.; female BALB/c nude mice) exhibits a long half-life (T1/2=8.13 h) and high plasma exposure (AUClast = 8061 h*ng/mL)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female BALB/c nude mice[1]
-
Dosage:2, 20 and 50 mg/kg(Pharmacokinetic Analysis)
-
Administration:Oral administration, intraperitoneal injection and intravenous injection
-
Result:
1.19 admin. p.o. i.p. i.v. Tmax (min) 0.83 0.18 Cmax (ng/mL) 171 78582 AUClast (h*ng/mL) 242 8061 408 T1/2 (h) 8.13 4.20 2.23 CL_obs (mL/min/kg) 81.10 F (%) 2.38 79.00
-
Animal Model:Female BALB/c nude mice[1]
-
Dosage:50 and 100 mg/kg
-
Administration:Intraperitoneal injection; daily; for 14 days
-
Result:Inhibited the growth of HT29 tumors at a dose of 50 mg/kg and inhibited the growth of MDA-MB-231 breast tumors in a dose-dependent manner.
Chemical Information
-
CAS No. 3031483-60-7
-
Molecular Weight 544.50
-
Formula C27H30BrNO4S
-
SMILES
OC[C@@H]1N(CC2=CC=C(COC3=CC(CS(=O)(C4=CC=CC=C4)=O)=C(Br)C(C)=C3)C=C2)CCC1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)